FUROSEMIDE tablet

Nchi: Marekani

Lugha: Kiingereza

Chanzo: NLM (National Library of Medicine)

Viambatanisho vya kazi:

FUROSEMIDE (UNII: 7LXU5N7ZO5) (FUROSEMIDE - UNII:7LXU5N7ZO5)

Inapatikana kutoka:

RedPharm Drug, Inc.

INN (Jina la Kimataifa):

FUROSEMIDE

Tungo:

FUROSEMIDE 20 mg

Njia ya uendeshaji:

ORAL

Dawa ya aina:

PRESCRIPTION DRUG

Matibabu dalili:

Edema FUROSEMIDE TABLET is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. FUROSEMIDE TABLET is particularly useful when an agent with greater diuretic potential is desired. Hypertension Oral FUROSEMIDE TABLET may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. Hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with FUROSEMIDE TABLETS alone. FUROSEMIDE TABLET is contraindicated in patients with anuria and in patients with a history of hypersensitivity to furosemide.

Bidhaa muhtasari:

FUROSEMIDE TABLET 20 mg are supplied as white, round tablets in Bottles of 100 (NDC 64125-116-01), and 1000 (NDC 64125-116-10). The 20 mg tablets are imprinted with "EP 116" on one side and plain on the other. FUROSEMIDE TABLETS 40 mg are supplied as white, round, scored tablets in Bottles of 100 (NDC 64125-117-01) and 1000 (NDC 64125-117-10). The 40 mg tablets are imprinted with "EP 117" on one side and "40" on the other. FUROSEMIDE TABLETS 80 mg are supplied as white, round, scored tablets in Bottles of 100 (NDC 64125-118-01) and 500 (NDC 64125-118-05). The 80 mg tablets are imprinted with "EP 118" on one side and "80" on the other. Note: Dispense in well-closed, light-resistant containers. Exposure to light might cause a slight discoloration. Discolored tablets should not be dispensed. Tested by USP Dissolution Test 2 Store at 25° C (77° F); excursions permitted to 15 to 30° C (59 to 86° F). [See USP Controlled Room Temperature.]

Idhini hali ya:

Abbreviated New Drug Application

Tabia za bidhaa

FUROSEMIDE- FUROSEMIDE TABLET
REDPHARM DRUG, INC.
----------
SPL UNCLASSIFIED SECTION
Rx only
WARNING
FUROSEMIDE TABLETS is a potent diuretic which, if given in excessive
amounts, can lead to a
profound diuresis with water and electrolyte depletion. Therefore,
careful medical supervision is
required and dose and dose schedule must be adjusted to the individual
patient's needs. (See DOSAGE
AND ADMINISTRATION.)
DESCRIPTION
FUROSEMIDE TABLET is a diuretic which is an anthranilic acid
derivative. FUROSEMIDE
TABLET for oral administration contain furosemide as the active
ingredient and the following inactive
ingredients: lactose anhydrous NF, magnesium stearate NF, starch NF,
microcrystalline cellulose NF,
sodium starch Glycolate NF, and colloidal silicon dioxide NF.
Chemically, it is 4-chloro-N-furfuryl-5-
sulfamoylanthranilic acid. FUROSEMIDE TABLET is available as white
tablets for oral administration
in dosage strengths of 20, 40 and 80 mg. Furosemide is a white to
off-white odorless crystalline
powder. It is practically insoluble in water, sparingly soluble in
alcohol, freely soluble in dilute alkali
solutions and insoluble in dilute acids.
The CAS Registry Number is 54-31-9.
It has a molecular formula of C12H11ClN2O5S and a molecular weight of
330.75.
The molecular structure is as follows:
[furosemide structure]
CLINICAL PHARMACOLOGY
Investigations into the mode of action of FUROSEMIDE TABLET have
utilized micropuncture studies
in rats, stop flow experiments in dogs and various clearance studies
in both humans and experimental
animals. It has been demonstrated that FUROSEMIDE TABLET inhibits
primarily the absorption of
sodium and chloride not only in the proximal and distal tubules but
also in the loop of Henle. The high
degree of efficacy is largely due to the unique site of action. The
action on the distal tubule is
independent of any inhibitory effect on carbonic anhydrase and
aldosterone.
Recent evidence suggests that furosemide glucuronide is the only or at
least the major
biotransformation product of furos